BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 9244671)

  • 1. [In what way and how intensively should blood pressure be lowered in diabetic nephropathy?].
    Krämer BK; Wieçek A; Ritz E
    Dtsch Med Wochenschr; 1997 Jun; 122(25-26):829-32. PubMed ID: 9244671
    [No Abstract]   [Full Text] [Related]  

  • 2. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
    Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S
    Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy of diabetic nephropathy].
    Barna I
    Orv Hetil; 2003 Jan; 144(4):165-72. PubMed ID: 12621814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Risk and prevention of diabetic nephropathy].
    Ravera M; Re M; Deferrari G
    G Ital Nefrol; 2007; 24 Suppl 38():13-9. PubMed ID: 17922442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diabetic nephropathy. Are the blood pressure values set too low?].
    Zidek W
    MMW Fortschr Med; 2003 Dec; 145(49):14. PubMed ID: 14963985
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapeutic controversies in hypertension management: angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers for diabetic nephropathy? A case for ACE inhibitors.
    Crook ED; Preddie DC
    Ethn Dis; 2002; 12(4):S3-49-52. PubMed ID: 12477155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Can progression to terminal renal insufficiency be avoided in diabetic nephropathy?].
    Luño J; Valderrábano F
    An Med Interna; 1998 Nov; 15(11):567-71. PubMed ID: 9882851
    [No Abstract]   [Full Text] [Related]  

  • 8. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L; Kocks MJ; Laverman GD; Navis G
    Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood pressure, diabetes and diabetic nephropathy.
    Chantrel F; Moulin B; Hannedouche T
    Diabetes Metab; 2000 Jul; 26 Suppl 4():37-44. PubMed ID: 10922972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kidney function after withdrawal of long-term antihypertensive treatment in diabetic nephropathy.
    Hansen HP; Nielsen FS; Rossing P; Jacobsen P; Jensen BR; Parving HH
    Kidney Int Suppl; 1997 Dec; 63():S49-53. PubMed ID: 9407421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward better renoprotection: lessons from angiotensin receptor blockers.
    Miyata T; Takizawa S
    Hemodial Int; 2007 Apr; 11(2):164-8. PubMed ID: 17403166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are newer antihypertensive agents really more effective than traditional drugs in progressive renal disease?
    Ritz E; Fliser D; Keller H; Reisch C
    Am J Kidney Dis; 1991 May; 17(5 Suppl 1):76-80. PubMed ID: 2024679
    [No Abstract]   [Full Text] [Related]  

  • 13. Renin angiotensin system blockade and nephropathy: why is it being called into question, and should it be?
    Hollenberg NK; Epstein M
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):1046-8. PubMed ID: 17699325
    [No Abstract]   [Full Text] [Related]  

  • 14. [Progression of chronic renal insufficiency and its prevention using angiotensin converting enzyme inhibitors and angiotensin antagonists].
    Tesar V
    Vnitr Lek; 2003 May; 49(5):365-9. PubMed ID: 12908169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Renal complications of diabetes].
    Tielemans C
    Rev Med Brux; 1995; 16(4):258-61. PubMed ID: 7481238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II receptor blockade in diabetic nephropathy.
    Andersen S
    Dan Med Bull; 2004 Aug; 51(3):274-94. PubMed ID: 16009059
    [No Abstract]   [Full Text] [Related]  

  • 17. Improving microvascular outcomes in patients with diabetes through management of hypertension.
    McGill JB
    Postgrad Med; 2009 Mar; 121(2):89-101. PubMed ID: 19332966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic effects of angiotensin II inhibition or blockade on the progression of chronic renal disease.
    Cantarovich F; Rangoonwala B
    Int J Clin Pract; 2003 Nov; 57(9):801-22. PubMed ID: 14686572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hypertension and diabetic nephropathy, a dangerous duo].
    Hausberg M; Hohage H; Kosch M
    Med Klin (Munich); 2005 Nov; 100(11):729-37; quiz 738-9. PubMed ID: 16328181
    [No Abstract]   [Full Text] [Related]  

  • 20. [Control of arterial pressure in diabetic nephropathy].
    Luño J; García de Vinuesa S
    Nefrologia; 2001; 21(3):240-5. PubMed ID: 11471304
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.